FEED Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

4.830

Open

2.240

VWAP

4.00

Vol

134.00M

Mkt Cap

3.00M

Low

2.200

Amount

499.00M

EV/EBITDA(TTM)

--

Total Shares

1.00M

EV

-1.00M

EV/OCF(TTM)

--

P/S(TTM)

0.00

ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.

Show More

Events Timeline

(ET)

2026-01-28

09:10:00

ENvue Medical Signs Distribution Agreement with U-Deliver

2026-01-21 (ET)

2026-01-21

08:40:00

ENvue Medical Appoints Marc Waldman as Vice President, Commercial

2026-01-14 (ET)

2026-01-14

08:40:00

ENvue Medical Launches OTC ENFit Syringes

2026-01-09 (ET)

2026-01-09

09:10:00

ENvue Medical Launches New Program to Improve Comfort of Nasogastric Tube Use

2025-12-18 (ET)

2025-12-18

09:10:00

ENvue Medical's UroShield Kit Added to UK NHS Drug Tariff

News

an image of Benzinga

10:03 AMBenzinga

Meta Platforms Reports Strong Q4 Earnings, Shares Surge

an image of stocktwits

01-28stocktwits

ENvue Partners with U-Deliver for Nationwide Syringe Distribution

an image of NASDAQ.COM

01-28NASDAQ.COM

ENvue Medical Partners with U-Deliver to Expand ENFit Syringe Distribution

an image of Benzinga

ENvue Medical Partners with U-Deliver for Nationwide Distribution of ENFit Syringes

an image of Benzinga

F5, Inc. Reports Strong Q1 Results and Raises FY26 Guidance

an image of Globenewswire

01-21Globenewswire

ENvue Medical Appoints Marc Waldman as VP of Commercial to Drive Revenue Growth

Valuation Metrics

The current forward P/E ratio for ENvue Medical Inc (FEED.O) is -0.00, compared to its 5-year average forward P/E of -0.00. For a more detailed relative valuation and DCF analysis to assess ENvue Medical Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-0.00

Current PE

-0.00

Overvalued PE

-0.00

Undervalued PE

-0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

0.87

Current PS

0.55

Overvalued PS

1.04

Undervalued PS

0.71

Financials

AI Analysis

Annual

Quarterly

Whales Holding FEED

Trading Trends

People Also Watch

Frequently Asked Questions

What is ENvue Medical Inc (FEED) stock price today?

The current price of FEED is 4.1188 USD — it has increased 79.09 % in the last trading day.

What is ENvue Medical Inc (FEED)'s business?

ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.

What is the price predicton of FEED Stock?

Wall Street analysts forecast FEED stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FEED is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is ENvue Medical Inc (FEED)'s revenue for the last quarter?

ENvue Medical Inc revenue for the last quarter amounts to 722.00K USD, increased 92.02 % YoY.

What is ENvue Medical Inc (FEED)'s earnings per share (EPS) for the last quarter?

ENvue Medical Inc. EPS for the last quarter amounts to -0.91 USD, decreased -97.68 % YoY.

How many employees does ENvue Medical Inc (FEED). have?

ENvue Medical Inc (FEED) has 15 emplpoyees as of January 29 2026.

What is ENvue Medical Inc (FEED) market cap?

Today FEED has the market capitalization of 3.00M USD.